In agreement with our studies, previous work from other labs demonstrated cisplatin mediated up-regulation of NK cell cytotoxicity through suppression of AR, and upregulation of ULBP-2 in the HCC tumor model (50). Here, ULBP2 is linked to hepatocellular carcinoma.